The Carlyle Group has paid an undisclosed sum for a significant minority stake in Ambio, a US-based pharmaceuticals company with substantial operations in China.
Special purpose acquisition companies, or SPACs, are staging a modest comeback in Asia on the back of a resurgence in the US. These structures offer considerable upside, but they aren’t for everyone
Japan Post Investment Corporation (JPIC), a direct investment unit launched by Japan Post Bank and Japan Post Insurance earlier this year, has joined a $94 million round for Japan-founded and US-based data company Cloudian.
David York, a managing partner at venture capital-focused fund-of-funds Top Tier Capital Partners, assesses the motivations behind the flood of capital into the US late-stage technology space
Los Angeles Fire & Police Pensions (LAFPP) has committed $25 million to Baring Private Equity Asia’s seventh pan-regional fund. It invested the same amount in the firm’s previous two vehicles.
Clobotics, a China and US-based computer vision start-up backed by a number of venture capital firms, has raised $11 million in Series A funding.
Sino-US venture capital firm GGV Capital is targeting $1.88 billion for its latest fund, which like its previous fund is grouped into four separate vehicles.
Nexus Venture Partners has led an $8 million Series A funding round for Observe.AI, a business process outsourcing (BPO) services provider based in the US and India.
US specialty retailer Brookstone, which was acquired in 2014 by Sailing Capital and Chinese retail conglomerate Sanpower Group, has filed for bankruptcy again and will close its 102 retail stores located in shopping malls.
US-based fitness services company ClassPass has raised a $85 million Series D round led by Temasek Holdings and L Catterton as part of a global expansion effort that will emphasize Southeast Asia.
Tenzing Acquisition, a blank check company headed by New Silk Route Ventures (NSR) co-founder and CEO Parag Saxena, has filed for a $50 million IPO on NASDAQ. The firm will use the proceeds to invest in companies with a focus on businesses operating in...
Connie Chan (pictured), the executive at US venture capital firm Andreessen Horowitz responsible for managing the Asian network, has been promoted to general partner.
Alternatives investment officers from US institutions should involve their senior leadership teams in site visits to Asia if they want to push ahead with emerging markets investment programs, LPs told the AVCJ USA Forum.
Jafco has led an $11 million funding round for Trillium, a cybersecurity company focused on the autonomous vehicle industry based in Japan and the US.
VCs continue to shun the field of supercomputing despite new commercial upside related to the rise of artificial intelligence. Asia, however, could offer a relatively competitive launchpad for start-ups in the segment
The emergence of domestically-developed tech business models in China that can be exported overseas has VC investors hoping the country can become known as an innovator rather than a copycat
Teams spinning out from US endowments are competing in an increasingly competitive market for outsourced investment mandates from institutions. Scale and differentiation are the key selling points
A long-smoldering trade dispute between the US and China has begun to reverberate globally across a range of sectors. Private equity must not ignore the potential impacts
Singapore’s EDBI has joined a $42 million funding round for Puppet, a US-based creator of software development and operation tools, with the goal of driving expansion in Asia.
World Innovation Lab (WiL) has raised $521 million for a US-Japan venture capital fund.
A global commercial property services provider that TPG Capital and PAG Asia Capital created through the merger of Australia’s DTZ with US-based Cassidy Turley and Cushman & Wakefield, has filed for a US IPO.
The Blackstone Group has achieved a final close on its maiden Asia-focused private equity fund at a revised hard cap of $2.3 billion.
Pivotal BioVenture Partners China, an investment platform of Hong Kong conglomerate Nan Fung Group, has led a $16.5 million seed round for Sino-US cancer drug developer Oncologie.
Cornerstone Capital, a China-based PE firm that focuses on pre-IPO investments, has filed for an IPO on NASDAQ.